Human Stem Cell Cloning: 'Holy Grail' or Techno-Fantasy?
By David King,
CNN
| 05. 17. 2013
(CNN) -- Today was a strange day. I'm used to handling the brief but overwhelming burst of media attention that comes with new stories about medical breakthroughs and ethical issues. But I don't often get an accompanying deluge of passionate e-mails and phone calls from people who had read my comments, denouncing me for criticizing science, especially medical research that "can save millions of lives."
There is definitely something special about this idea of "therapeutic cloning," something that has a religious feel to it. Most of those messages come from people who have family members suffering from some of the diseases that we are told will be cured, and it's hard to have to pour cold water on people's hopes.
I feel really angry at the scientists and PR people who have sold the idea of cloned human stem cells to so many patient support groups, when there is so little scientific substance to their promises. We are told that there will be great medical benefits and that the risks that there will be cloned babies are small, but in...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...